1.0
Feb 7, 2016
Recommend
CEO approval
Business Outlook
Pros
Novel product that will hopefully help Cancer patients.
Cons
Inexperienced management with only small company clinical research experience, not willing to improve and learn best ways to conduct clinical trials according to GCP.